Kingswood nears takeover deal with PE backer HSQ Investments

HSQ initially invested in Kingswood in 2019

Sahar Nazir
clock • 2 min read

Kingswood has confirmed it is in advanced discussions with HSQ Investments (HSQ), a subsidiary of Pollen Street Capital, regarding a possible cash offer for the entire issued and to be issued share capital of the company not already owned by HSQ.

HSQ initially invested in Kingswood in September 2019, injecting up to £80m in growth equity capital to support the business. HSQ currently holds 68.4% of Kingswood's voting rights. Kingswood said it has been impacted by "headwinds seen across the sector over the last couple of years", despite HSQ's investment. This resulted in the company's growth not being as strong over the period as management had expected, it set out. Assura receives cash offer from KKR and Stonepeak Partners In conjunction with this, its acquisition strategy has seen the company's debt position increase signi...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Companies

Monzo fined £21m by FCA for failings in financial crime controls

Monzo fined £21m by FCA for failings in financial crime controls

Around 34,000 high-risk clients onboarded

Linus Uhlig
clock 08 July 2025 • 2 min read
Citi becomes minority investor in HANetf

Citi becomes minority investor in HANetf

Growing interest in European ETFs

Patrick Brusnahan
clock 03 July 2025 • 2 min read
AstraZeneca CEO mulls moving listing to the US – reports

AstraZeneca CEO mulls moving listing to the US – reports

Latest blow to LSE

Linus Uhlig
clock 02 July 2025 • 1 min read
Trustpilot